Evidence map›Paper›PMID 35590961›Full record

ArticleSensors (Basel, Switzerland)2022

Hybrid Loss-Constrained Lightweight Convolutional Neural Networks for Cervical Cell Classification.

Wen Chen, Weiming Shen, Liang Gao, Xinyu Li

Abstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Optimizing cervical cancer diagnosis with accurate cell classification using modified HDFF.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Wen ChenState Key Laboratory of Digital Manufacturing Equipment & Technology, Huazhong University of Science and Technology, Wuhan 430074, China.
Weiming ShenState Key Laboratory of Digital Manufacturing Equipment & Technology, Huazhong University of Science and Technology, Wuhan 430074, China.ORCID 0000-0001-5204-7992
Liang GaoState Key Laboratory of Digital Manufacturing Equipment & Technology, Huazhong University of Science and Technology, Wuhan 430074, China.ORCID 0000-0002-1485-0722
Xinyu LiState Key Laboratory of Digital Manufacturing Equipment & Technology, Huazhong University of Science and Technology, Wuhan 430074, China.

Funding

Fundamental Research Funds for the Central Universities of China 2021GCRC058
6 · The paper itself

Abstract

Artificial intelligence (AI) technologies have resulted in remarkable achievements and conferred massive benefits to computer-aided systems in medical imaging. However, the worldwide usage of AI-based automation-assisted cervical cancer screening systems is hindered by computational cost and resource limitations. Thus, a highly economical and efficient model with enhanced classification ability is much more desirable. This paper proposes a hybrid loss function with label smoothing to improve the distinguishing power of lightweight convolutional neural networks (CNNs) for cervical cell classification. The results strengthen our confidence in hybrid loss-constrained lightweight CNNs, which can achieve satisfactory accuracy with much lower computational cost for the SIPakMeD dataset. In particular, ShufflenetV2 obtained a comparable classification result (96.18% in accuracy, 96.30% in precision, 96.23% in recall, and 99.08% in specificity) with only one-seventh of the memory usage, one-sixth of the number of parameters, and one-fiftieth of total flops compared with Densenet-121 (96.79% in accuracy). GhostNet achieved an improved classification result (96.39% accuracy, 96.42% precision, 96.39% recall, and 99.09% specificity) with one-half of the memory usage, one-quarter of the number of parameters, and one-fiftieth of total flops compared with Densenet-121 (96.79% in accuracy). The proposed lightweight CNNs are likely to lead to an easily-applicable and cost-efficient automation-assisted system for cervical cancer diagnosis and prevention.

Indexed as

Artificial IntelligenceUterine Cervical NeoplasmsAutomationEarly Detection of CancerFemaleHumansNeural Networks, Computercervical cancer diagnosisdeep learninghybrid loss functionlightweight convolutional neural networksmedical imaging

Identifiers

PMID35590961
PMCPMC9101629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.